Singapore markets close in 2 minutes
Straits Times Index
3,122.57 +20.64 (+0.67%) Nikkei
27,927.37 -102.20 (-0.36%) Hang Seng
23,349.38 -417.31 (-1.76%) FTSE 100
7,181.70 +59.38 (+0.83%) BTC-USD
48,229.71 -1,313.48 (-2.65%) CMC Crypto 200
1,233.14 -208.62 (-14.47%)
BioCryst Pharmaceuticals, Inc. (BCRX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 2.06B |
| Enterprise value | 2.03B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/sales (ttm) | 17.84 |
| Price/book (mrq) | 56.59 |
| Enterprise value/revenue | 17.78 |
| Enterprise value/EBITDA | -11.27 |
Trading information
Stock price history
| Beta (5Y monthly) | 2.49 |
| 52-week change 3 | 58.45% |
| S&P500 52-week change 3 | 22.93% |
| 52-week high 3 | 18.48 |
| 52-week low 3 | 6.46 |
| 50-day moving average 3 | 13.57 |
| 200-day moving average 3 | 13.98 |
Share statistics
| Avg vol (3-month) 3 | 2.76M |
| Avg vol (10-day) 3 | 2.91M |
| Shares outstanding 5 | 179.94M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 165.69M |
| % held by insiders 1 | 0.91% |
| % held by institutions 1 | 58.43% |
| Shares short (14 Nov 2021) 4 | 22.55M |
| Short ratio (14 Nov 2021) 4 | 7.36 |
| Short % of float (14 Nov 2021) 4 | 14.08% |
| Short % of shares outstanding (14 Nov 2021) 4 | 12.53% |
| Shares short (prior month 14 Oct 2021) 4 | 18.97M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | N/A |
| Trailing annual dividend yield 3 | N/A |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2020 |
| Most-recent quarter (mrq) | 29 Sep 2021 |
Profitability
| Profit margin | -198.88% |
| Operating margin (ttm) | -160.46% |
Management effectiveness
| Return on assets (ttm) | -51.75% |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | 114.03M |
| Revenue per share (ttm) | 0.64 |
| Quarterly revenue growth (yoy) | 571.80% |
| Gross profit (ttm) | -106.83M |
| EBITDA | -182.19M |
| Net income avi to common (ttm) | -226.78M |
| Diluted EPS (ttm) | -1.27 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 199.6M |
| Total cash per share (mrq) | 1.11 |
| Total debt (mrq) | 310.65M |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 1.89 |
| Book value per share (mrq) | -0.82 |
Cash flow statement
| Operating cash flow (ttm) | -154.34M |
| Levered free cash flow (ttm) | -103.06M |
© 2021 Yahoo. All rights reserved.
